Indeferimento
#9.2
12/03/2024
RPI 2813
Application data
Number
112019010003Type
Filing
Publication
PCT
US2017061875 The application was refused by the INPI on 12/03/2024. The invention was never patented.
Talk to a specialistLatest action published by the INPI: 12/03/2024. We update with every new RPI gazette, published weekly.
Applicants
ABIDE THERAPEUTICS, INC.
US
H. LUNDBECK A/S
DK
LUNDBECK LA JOLLA RESEARCH CENTER, INC.
US
Inventors
C. B. (pessoa física)
US
C. G. (pessoa física)
US
J. B. (pessoa física)
US
K. G. (pessoa física)
US
T. J. (pessoa física)
US
IPC Classification
Priority claims
US
62/423,126 · 11/16/2016
Abstract
É descrito no presente documento o inibidor de MAGL 4-(2-(pirrolidin-1-il)-4-(trifluorometil)benzil)piperazina-1-carboxilato de 1,1,1,3,3,3-hexafluoropropan-2-ila, incluindo formas cristalinas e sais e solvatos farmaceuticamente aceitáveis do mesmo.
Publications in the Brazilian Industrial Property Gazette (RPI).
#9.2
12/03/2024
RPI 2813
#7.1
08/20/2024
RPI 2798
#15.35
10/05/2021
RPI 2648
#6.23
10/05/2021
RPI 2648
#15.11
As Classificações Anteriores eram: C07D 403/00 , C07D 213/55
06/15/2021
RPI 2632
#25.1
02/09/2021
RPI 2614
#25.4
01/19/2021
RPI 2611
#1.3
08/20/2019
RPI 2537
#1.1
05/28/2019
RPI 2525
From the same holder
Same category
Patent monitoring
Receive alerts on INPI events, decisions, and expiry dates for your portfolio.